Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02564900
Title Study of DS-8201a in Subjects With Advanced Solid Malignant Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Daiichi Sankyo Co., Ltd.
Indications

gastroesophageal junction adenocarcinoma

breast cancer

Advanced Solid Tumor

gastric adenocarcinoma

Therapies

Trastuzumab deruxtecan

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Sharp Memorial Hospital San Diego California 92123 United States Details
Mayo Clinic Jacksonville Florida 32224 United States Details
University of Louisville Louisville Kentucky 40202 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02215 United States Details
Washington University School of Medicine Saint Louis Missouri 63110 United States Details
Memorial Sloan-Kettering Cancer Center New York New York 10065 United States Details
UC Health Clinical Trials Office Cincinnati Ohio 45229 United States Details
University of Texas M. D. Anderson Cancer Center Houston Texas 77030-3721 United States Details
Aichi Cancer Center Hospital Aichi Japan Details
National Cancer Center Hospital East Chiba Japan Details
Social Medical Corporation Hakuaikai Sagara Hospital Kagoshima Japan Details
Kindai University Hospital Osaka Japan Details
National Cancer Center Hospital Tokyo Japan Details
The Cancer Institute Hospital of Japanese Foundation For Cancer Research Tokyo Japan Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field